Covidien plc news

   Watch this stock
Showing stories 1 - 10 of about 103   

Articles published

COV 106.71 0.00 (0.00%)
price chart
Announcement under Irish Takeover Rules -- Results of Covidien plc's ...
This Announcement is Being Made Solely to Comply with the Requirements of the Irish Takeover Rules. the Information Set out Herein Concerning the Results of Covidien plc's Shareholder Meetings on January 6, 2015 Will Also Be Set out in Covidien plc's ...
Medtronic, Covidien Settle Shareholder Suit Over $42.9B Merger  Med Device Online (press release)
Related articles »  
Covidien plc (COV) Remains on CreditWatch Positive at S&P (MDT)
Standard & Poor's Ratings Services today said its ratings on Covidien plc (NYSE: COV), including its 'A' corporate credit rating and issue-level ratings, remain on CreditWatch with positive implications.
Covidien Rises as Medtronic Reveals New Financing Plan  Zacks.com
Medtronic alters financial structure for Covidien deal  Memphis Business Journal
Related articles »  
Chilton Investment Company raises its stake in Covidien plc
Chilton Investment Company started new positions in Sonic Corporation (SONC), Endo International plc (ENDP), Apache Corporation (APA), and Realogy Holdings Corp.
Medtronic Completes Covidien Acquisition for $50B - Analyst Blog
Per the terms of this agreement, Medtronic, Inc. and Covidien plc will now become wholly-owned subsidiaries of the new combined holding company - Medtronic plc, with its principal executive offices based in Ireland.
Medtronic completes Covidien merger after Irish court approval  TwinCities.com-Pioneer Press
Medtronic's Pending Acquisition of Covidien Approved by Irish High Court  Yahoo Finance UK
Covidien plc to Report First-Quarter Fiscal 2015 Results on January 22, 2015
DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report first-quarter fiscal 2015 results on January 22. Results will be filed via Form 8K and available prior to market open at www.
Medtronic Sales Beat Analysts' Estimates After Covidien Deal
Medtronic Plc, the world's biggest maker of heart-rhythm devices, reported preliminary fourth-quarter revenue that beat analysts' estimates, its first financial results since the acquisition of Covidien Plc. Sales of $7.3 billion in the quarter that ...
Medtronic fiscal Q4 revenues up 60% with inclusion on Covidien (MDT)  Seeking Alpha
Medtronic posts higher preliminary quarterly revenue  Reuters
Covidien plc. (COV) Ex-Dividend Date Scheduled for December 30, 2014
will begin trading ex-dividend on December 30, 2014. A cash dividend payment of $0.36 per share is scheduled to be paid on January 16, 2015.
Medtronic Profit Beats Estimates After Covidien Purchase
Medtronic Plc, the world's biggest maker of heart-rhythm devices, reported quarterly earnings that beat analysts' estimates following its $49.9 billion acquisition of Covidien Plc. In the quarter ended in April -- the first full period since the ...
Medtronic swings to loss after Covidien deal  MarketWatch
Medtronic Swings to Loss in First Quarter After Covidien Deal  Wall Street Journal
Do Hedge Funds Hate Covidien PLC (COV)?
Covidien PLC (COV) hedge funds sentiment decreased to 0 in Q1 2015. Its down -0.78, from 0.78 in 2014Q4. The sentiment turned negative, as 0 active investment managers started new and increased positions, while 680 trimmed and sold holdings in ...
Covidien plc (COV) Granted Prelim. Injunction Against Johnson & Johnson's (JNJ ...
Covidien plc (NYSE: COV) announced that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against Ethicon Endo-Surgery, Inc., a Johnson & Johnson (NYSE: JNJ) company.
Court Grants Injunction in Covidien Patent Case Against J&J  Wall Street Journal
Related articles »